Iulian Cioanta - May 15, 2025 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)

Role
Chief Sci. and Tech. Officer
Signature
/s/ Griffin D. Foster as Attorney-in-Fact for Iulian Cioanta
Stock symbol
SNWV
Transactions as of
May 15, 2025
Transactions value $
-$57,862
Form type
4
Date filed
5/16/2025, 04:48 PM
Previous filing
Jan 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cioanta Iulian Chief Sci. and Tech. Officer 11495 VALLEY VIEW ROAD, EDEN PRAIRIE /s/ Griffin D. Foster as Attorney-in-Fact for Iulian Cioanta 2025-05-16 0002012325

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNWV Common Stock Options Exercise $25.2K +1.78K +4334.15% $14.20 1.82K May 15, 2025 Direct
transaction SNWV Common Stock Options Exercise $11.9K +529 +29.1% $22.50 2.35K May 15, 2025 Direct
transaction SNWV Common Stock Options Exercise $20K +1.33K +56.8% $15.00 3.68K May 15, 2025 Direct
transaction SNWV Common Stock Sale -$115K -3.64K -98.89% $31.60 41 May 15, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNWV Stock Option (right to buy) Options Exercise $0 -1.78K -16.66% $0.00 8.89K May 15, 2025 Common Stock 1.78K $14.20 Direct F1
transaction SNWV Stock Option (right to buy) Options Exercise $0 -529 -100% $0.00 0 May 15, 2025 Common Stock 529 $22.50 Direct F2
transaction SNWV Stock Option (right to buy) Options Exercise $0 -1.33K -100% $0.00 0 May 15, 2025 Common Stock 1.33K $15.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Iulian Cioanta is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Options vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date, October 22, 2024.
F2 Fully vested.